Naik, S.; Rakszawski, K.; Zheng, H.; Claxton, D.; Minagawa, K.; Mineishi, S.
Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia. Int. J. Mol. Sci. 2024, 25, 957.
https://doi.org/10.3390/ijms25020957
AMA Style
Naik S, Rakszawski K, Zheng H, Claxton D, Minagawa K, Mineishi S.
Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia. International Journal of Molecular Sciences. 2024; 25(2):957.
https://doi.org/10.3390/ijms25020957
Chicago/Turabian Style
Naik, Seema, Kevin Rakszawski, Hong Zheng, David Claxton, Kentaro Minagawa, and Shin Mineishi.
2024. "Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia" International Journal of Molecular Sciences 25, no. 2: 957.
https://doi.org/10.3390/ijms25020957
APA Style
Naik, S., Rakszawski, K., Zheng, H., Claxton, D., Minagawa, K., & Mineishi, S.
(2024). Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia. International Journal of Molecular Sciences, 25(2), 957.
https://doi.org/10.3390/ijms25020957